LACTATE METERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

The global demand for lactate testing is increasing substantially owing to its crucial role in clinical diagnosis of various metabolic disorders. Lactate meters have emerged as convenient point-of-care diagnostic tools to measure lactate levels through minor blood samples. Doctors can now easily monitor lactate levels in patients suffering from conditions like diabetes, cardio-vascular diseases, respiratory illnesses, liver dysfunction, cancer, etc. during routine examinations or emergency treatments. Lactate is considered as an important biomarker or vital sign along with parameters like blood pressure, heart rate, etc. Its timely detection helps medical practitioners make quick clinical decisions, diagnose underlying metabolic causes, evaluate the severity of a disease as well as effectiveness of ongoing treatments. This has significantly boosted the adoption of lactate meters across hospitals, clinics, emergency rooms, and ambulatory surgical centers. For example, according to data from the World Health Organization (2020), metabolic disorders accounted for over 40% of global disease burden and were among the leading causes of mortality. Early screening for lactate levels is proving highly beneficial for improving health outcomes in such patients.

• Nova Biomedical
• EKF Diagnostics
• ApexBio
• ARKRAY, Inc.
• Sensa Core Medical
• TAIDOC TECHNOLOGY CORPORATION
• F. Hoffmann-La Roche Ltd
• Jorgensen Labs
• Medtronic
• Nemaura